The COVID-19 vaccines have been described by many as the light at the end of the tunnel and the best tool we have to stop this pandemic. But along with the vaccine rollout, there have been a number of myths circulating about their safety and effectiveness. To set the record straight, Cedars-Sinai's Newsroom talked with Priya Soni, MD, a pediatrician and an infectious disease specialist.
Where do the greatest risks of infection lurk? How can you protect yourself and others even better? Scientists all over the world are working to expand knowledge about Covid-19 – including at Empa. Researchers are now using measurements and simulations to take a close look at cable cars and cabins in ski resorts.
Innova Medical Group, Inc., the world's largest manufacturer of rapid antigen test kits and leader in COVID-19 testing solutions globally, confirmed today that the company's SARS-CoV-2 Antigen Test kits have successfully detected the several mutated strains that have become more widespread around the world in recent weeks.
A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.
An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by reducing the virus' ability to attach to human cells and infect them.
The emergence of SARS-CoV-2 virus variants that are adding twists in the battle against COVID-19 highlight the need for better genomic monitoring of the virus, says Katia Koelle, associate professor of biology at Emory University.
Routine screening of asymptomatic health care personnel (HCP) in the absence of confirmed exposures to COVID-19 is not a recommended strategy for preventing transmission of the coronavirus causing the current global pandemic, according to a new review co-authored by an infectious disease specialist at Massachusetts General Hospital (MGH).
A new modelling study has estimated that from 2000 to 2030 vaccination against 10 major pathogens - including measles, rotavirus, HPV and hepatitis B - will have prevented 69 million deaths in low-income and middle-income countries (LMICs).
A remarkable number of pharmaceutical company leaders and chief scientists will come together at a two-day symposium to present efficacy data and updates on twelve vaccines and vaccines candidates. This includes the Moderna and Pfizer mRNA vaccines that have been approved in the US for emergency use. Other topics will include: the clinical epidemiology of COVID-19; the virology, immunology, and genetics of SARS-CoV-2; and research on COVID-19 vaccines in in the elderly.
The AAVCOVID vaccine program, a novel gene-based vaccine strategy that utilizes an adeno-associated virus (AAV) vector, was granted an award for up to $2.1 million from the Bill & Melinda Gates Foundation. In data released in preprint, two AAVCOVID vaccine candidates led to robust neutralizing antibody responses in mouse and nonhuman primate models from only a single dose. The candidates were also shown to be safe and well-tolerated in both models.
A research team from HSE University and SkolTech, together with experts from the Smorodintsev Research Institute of Influenza in St. Petersburg and the RAS Kharkevich Institute for Information Transmission Problems (IITP), discovered that the SARS-CoV-2 virus independently entered Russia at least 67 times, mostly at the end of February and beginning of March 2020.
Shared video of Dr. Fauci CNN interview with added commentary sends wrong message about COVID vaccine protection
For Michigan State University’s Felicia Wu, the surprise isn’t that people who work with livestock are at higher risk of picking up antibiotic-resistant bacteria, but instead how much higher their risk levels are. “This is a bit of a wakeup call,” said Wu, John. A Hannah Distinguished Professor in the Departments of Food Science and Human Nutrition and Agricultural, Food and Resource Economics. “I don’t think there was much awareness that swine workers are at such high risk, for example. Or that large animal vets are also at extremely high risk.”
A new vaccine development platform has proven effective in protecting against deadly, hard-to-treat infections caused by multi-drug resistant (MDR) bacteria, thanks to a collaborative endeavor led by Dr. Michael J. Daly, a professor in the Uniformed Services University's (USU) Department of Pathology, Dr. Gregory J. Tobin, president of Biological Mimetics, Inc., and Dr. Daniel Zurawski at the Walter Reed Army Institute of Research. This could ultimately help prevent battlefield infections, as well as common hospital-acquired infections in patients undergoing routine surgeries.
Flu cases are down this year, mostly because all the COVID-19 precautions like hand-washing and social distancing. That doesn’t mean you shouldn’t stay vigilant. In fact, it might be more important now than ever.
Among infectious diseases that have caused pandemics and epidemics, smallpox stands out as a success story. Smallpox vaccination led to the disease's eradication in the twentieth century.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right